JP2008522630A5 - - Google Patents

Download PDF

Info

Publication number
JP2008522630A5
JP2008522630A5 JP2007545722A JP2007545722A JP2008522630A5 JP 2008522630 A5 JP2008522630 A5 JP 2008522630A5 JP 2007545722 A JP2007545722 A JP 2007545722A JP 2007545722 A JP2007545722 A JP 2007545722A JP 2008522630 A5 JP2008522630 A5 JP 2008522630A5
Authority
JP
Japan
Prior art keywords
cell line
recombinant adenovirus
deposited
name
accession number
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007545722A
Other languages
English (en)
Japanese (ja)
Other versions
JP4621743B2 (ja
JP2008522630A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/045097 external-priority patent/WO2006065827A2/en
Publication of JP2008522630A publication Critical patent/JP2008522630A/ja
Publication of JP2008522630A5 publication Critical patent/JP2008522630A5/ja
Application granted granted Critical
Publication of JP4621743B2 publication Critical patent/JP4621743B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007545722A 2004-12-13 2005-12-12 複製欠損アデノウイルスの産生のための細胞株 Expired - Fee Related JP4621743B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63556104P 2004-12-13 2004-12-13
US67448805P 2005-04-25 2005-04-25
PCT/US2005/045097 WO2006065827A2 (en) 2004-12-13 2005-12-12 Cell lines for production of replication-defective adenovirus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010199416A Division JP2011015696A (ja) 2004-12-13 2010-09-06 複製欠損アデノウイルスの産生のための細胞株

Publications (3)

Publication Number Publication Date
JP2008522630A JP2008522630A (ja) 2008-07-03
JP2008522630A5 true JP2008522630A5 (https=) 2010-10-21
JP4621743B2 JP4621743B2 (ja) 2011-01-26

Family

ID=36282846

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007545722A Expired - Fee Related JP4621743B2 (ja) 2004-12-13 2005-12-12 複製欠損アデノウイルスの産生のための細胞株
JP2010199416A Withdrawn JP2011015696A (ja) 2004-12-13 2010-09-06 複製欠損アデノウイルスの産生のための細胞株

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010199416A Withdrawn JP2011015696A (ja) 2004-12-13 2010-09-06 複製欠損アデノウイルスの産生のための細胞株

Country Status (8)

Country Link
US (1) US7851218B2 (https=)
EP (1) EP1831352B1 (https=)
JP (2) JP4621743B2 (https=)
CN (1) CN101208425B (https=)
AT (1) ATE516343T1 (https=)
CA (1) CA2590943C (https=)
MX (1) MX2007007145A (https=)
WO (1) WO2006065827A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5213298B2 (ja) 2002-05-27 2013-06-19 ホルム，ペル・ゾンネ アデノウイルスおよびそれをコードしている核酸の新たな使用
CA2546178A1 (en) 2003-11-14 2005-06-09 Per Sonne Holm New use of adenovirus and nucleic acids coding therefor
US7851218B2 (en) 2004-12-13 2010-12-14 Schering Corporation Cell lines for production of replication-defective adenovirus
US20090232800A1 (en) * 2004-12-31 2009-09-17 Per Sonne Holm E1-minus adenoviruses and use thereof
DE602006019916D1 (de) * 2005-12-12 2011-03-10 Canji Inc Adenovirale expressionsvektoren mit einer expressionskassette im e1-bereich und einer inaktivierten e2b-polymerase
WO2011046757A2 (en) * 2009-10-12 2011-04-21 Rajabrata Sarkar Accelerating thrombus resolution through augmentation of p53 activity
US9233153B2 (en) * 2011-10-05 2016-01-12 Genvec, Inc. Affenadenovirus (gorilla) or adenoviral vectors and methods of use
CN103987726B (zh) 2011-10-05 2017-10-03 金维克有限公司 猴(大猩猩)腺病毒或腺病毒载体及其使用方法
JP6757120B2 (ja) 2011-10-05 2020-09-16 ジェンヴェック エルエルシー アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法
KR101427200B1 (ko) 2011-11-24 2014-08-07 주식회사 바이로메드 아데노바이러스 생산 신규 세포주 및 그의 용도
HK1210475A1 (en) 2012-05-29 2016-04-22 Genvec, Inc. Herpes simplex virus vaccine
MX2015014438A (es) 2013-04-18 2016-05-18 Armo Biosciences Inc Metodos de uso de interleucina-10 para tratar enfermedades y trastornos.
KR20180038553A (ko) 2015-08-25 2018-04-16 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
CN110832072B (zh) * 2017-04-21 2023-11-07 真基因太科公司 用于生产非复制型腺病毒的细胞系以及制备所述细胞系的方法
JP6997287B2 (ja) * 2017-07-10 2022-02-03 ジェン－プローブ・インコーポレーテッド 試料割り当てパラメータを使用した核酸増幅のための分析システムおよび方法
EP4079750A3 (en) * 2018-11-21 2023-01-04 Mayo Foundation for Medical Education and Research Adenoviruses and methods for using adenoviruses
CN114901828A (zh) * 2019-12-30 2022-08-12 南京金斯瑞生物科技有限公司 一种哺乳动物表达系统使用的高表达载体
US12227754B2 (en) 2020-04-07 2025-02-18 Lung Biotechnology Pbc Adenoviral expression vector and methods and cell lines for production
CN113736780B (zh) * 2020-05-28 2024-05-28 暨南大学 一种敲除p300基因的BCBL1细胞系及其构建方法与应用
CN114262691A (zh) * 2020-09-16 2022-04-01 杭州康万达医药科技有限公司 分离的能够用于表达外源基因的溶瘤腺病毒、载体、治疗剂及其用途
CN112156181A (zh) * 2020-09-29 2021-01-01 广州恩宝生物医药科技有限公司 一种腺病毒四价疫苗
CN117264902A (zh) * 2022-06-15 2023-12-22 上海元宋生物技术有限公司 一种腺病毒包装与生产细胞系的构建方法及应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835557B1 (en) * 1980-01-08 2004-12-28 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
TW442569B (en) * 1993-10-25 2001-06-23 Canji Inc Recombinant adenoviral vector
US6210939B1 (en) * 1993-10-25 2001-04-03 Canji, Inc. Recombinant adenoviral vector and methods of use
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
IL160406A0 (en) * 1995-06-15 2004-07-25 Crucell Holland Bv A cell harbouring nucleic acid encoding adenoritus e1a and e1b gene products
US6392069B2 (en) * 1996-01-08 2002-05-21 Canji, Inc. Compositions for enhancing delivery of nucleic acids to cells
US5789244A (en) * 1996-01-08 1998-08-04 Canji, Inc. Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems
US5891690A (en) * 1996-04-26 1999-04-06 Massie; Bernard Adenovirus E1-complementing cell lines
US6248514B1 (en) * 1996-07-09 2001-06-19 Canji, Inc. Methods for measuring viral infectivity
US6544769B1 (en) * 1996-12-13 2003-04-08 Schering Corporation Compostions comprising viruses and methods for concentrating virus preparations
US6261823B1 (en) * 1996-12-13 2001-07-17 Schering Corporation Methods for purifying viruses
US6146891A (en) * 1997-01-31 2000-11-14 Schering Corporation Methods for cultivating cells and propagating viruses
IL137510A0 (en) 1998-02-17 2001-07-24 Schering Corp Compositions comprising viruses and methods for concentrating virus preparations
US6670188B1 (en) * 1998-04-24 2003-12-30 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US5994134A (en) * 1998-05-04 1999-11-30 Canji, Inc. Viral production process
US7001770B1 (en) * 1998-10-15 2006-02-21 Canji, Inc. Calpain inhibitors and their applications
US7691370B2 (en) * 1998-10-15 2010-04-06 Canji, Inc. Selectivity replicating viral vector
US6649158B1 (en) * 1998-10-15 2003-11-18 Canji, Inc. Methods and compositions to induce antitumor response
US6430595B1 (en) * 1999-05-20 2002-08-06 Cisco Technology, Inc. Method and apparatus for establishing a database used for correlating information gathered via SNMP
US20020064860A1 (en) * 2000-11-29 2002-05-30 Schering Corporation Method for purifying adenoviruses
CA2528136A1 (en) 2003-06-04 2004-12-16 Canji, Inc. Transfection agents
US7026164B2 (en) * 2003-07-03 2006-04-11 Cell Genesys, Inc. Adenovirus packaging cell lines
SG133594A1 (en) 2003-12-10 2007-07-30 Canji Inc Methods and compositions for treatment of interferon-resistant tumors
US7851218B2 (en) 2004-12-13 2010-12-14 Schering Corporation Cell lines for production of replication-defective adenovirus
DE112007000879A5 (de) 2006-02-10 2009-01-15 Freie Universität Berlin Verfahren und Vorrichtung zum Präparieren von biologischen Proben

Similar Documents

Publication Publication Date Title
JP2008522630A5 (https=)
JP2020022459A5 (https=)
NZ595305A (en) Methods and reagents for treatment and diagnosis of age-related macular degeneration
JP2010531148A5 (https=)
JP2010273685A5 (https=)
JP2008245635A5 (https=)
JP2007175057A5 (https=)
AU2014203512B2 (en) Recombinant virus-like particles encoded by multi-gene vector
WO2009116861A3 (en) Diagnostic of pre-symptomatic metabolic syndrome
KR102160486B1 (ko) 돼지생식기호흡기증후군(prrs) 바이러스 유전형 판별용 pna 프로브 및 이를 이용한 돼지생식기호흡기증후군(prrs) 유전형 판별방법
JP2012531205A5 (https=)
JP2011500592A5 (https=)
JP2007075118A5 (https=)
MY163972A (en) Attenuated recombinant newcastle disease virus and vaccine containing the same
JP2009523007A5 (https=)
EP2383343A3 (en) Recombinant varicella-zoster virus
CN111218477A (zh) 靶向感染哺乳动物细胞的禽4型腺病毒载体及其应用
ATE432337T1 (de) Probiotische bifidobacterium arten
IL179911A0 (en) Methods related to a single nucleotide polymorphism of the g protein coupled receptor, gpr40
CN101255477B (zh) 栉孔扇贝g-型溶菌酶基因多态性标记筛选及其辅助育种方法
JP2006507816A5 (https=)
EP2434018A3 (en) A novel beta-galactoside-alpha2, 3-sialyltransferase, a gene encoding thereof, and a method for producing thereof
CA2624544A1 (en) Vero cell line adapted to grow in suspension
JP2007513601A5 (https=)
Lv et al. Transcriptional difference between SARS-COV-2 and other human coronaviruses revealed by sub-genomic RNA profiling